BDBM508641 8-[(2R)-2-(2-cyclopropyl-6,7-dihydro [1,3]oxazolo[5,4-c]pyridin-5(4H)- yl)propyl]-2,2-difluoro[1,3] dioxolo[4,5-h][1,2,4]triazolo[1,5- c]quinazolin-5-amine::US11046714, Example 81

SMILES C[C@H](Cc1nc2c3ccc4OC(F)(F)Oc4c3nc(N)n2n1)N1CCc2nc(oc2C1)C1CC1

InChI Key InChIKey=PBPWGFJIPVYYFA-SNVBAGLBSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 508641   

TargetAdenosine receptor A2a(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM508641(8-[(2R)-2-(2-cyclopropyl-6,7-dihydro [1,3]oxazolo[...)
Affinity DataKi:  2.40nMAssay Description:The following table shows representative data for the compounds of the Examples as A2a receptor antagonists as determined by a competition binding as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent